Pre-Analytical Automation Market Global Report 2026

The pre-analytical automation market size has grown strongly in recent years. It will grow from $7.04 billion in 2025 to $7.74 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising demand for high throughput diagnostic testing, increasing laboratory workload and sample volumes, growing need to reduce human errors in sample handling, expansion of clinical laboratory networks, and adoption of basic automation in specimen processing.

The pre-analytical automation market size is expected to see rapid growth in the next few years. It will grow to $11.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing adoption of ai enabled laboratory automation systems, rising demand for precision diagnostics and faster turnaround times, expansion of integrated healthcare laboratory networks, growing investment in smart hospital infrastructure, increasing focus on standardization and quality control in diagnostics. Major trends in the forecast period include ai driven laboratory workflow optimization for pre analytical sample processing automation, robotic sample handling systems for high throughput diagnostic laboratories, integrated laboratory information systems for end to end pre analytical data tracking, smart barcode and specimen identification systems for error free sample management, modular automated sample transport and sorting systems for improved laboratory efficiency.

The growing prevalence of infectious diseases is expected to drive the growth of the pre-analytical automation market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms that can spread between individuals or through environmental exposure. The rising prevalence of infectious diseases is attributed to increasing urbanization, where high population density facilitates faster transmission of pathogens. Pre-analytical automation supports infectious disease diagnostics by streamlining and standardizing early laboratory workflows, enabling faster, more accurate, and contamination-reduced processing of clinical samples for timely detection and surveillance. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Therefore, the growing prevalence of infectious diseases is driving the growth of the pre-analytical automation market.

Major companies operating in the pre-analytical automation market are focusing on developing innovative solutions such as integrated sample preparation platforms to standardize workflows, reduce manual handling errors, and enhance overall laboratory efficiency and diagnostic accuracy. Integrated sample preparation platforms are automated systems that simplify early laboratory processes by combining multiple steps such as aliquoting, mixing, labeling, and sample preparation into a single streamlined workflow, helping ensure consistency and traceability compared to traditional methods that are slower and more variable. For instance, in April 2026, Invivoscribe Inc., a US-based molecular diagnostics company, launched the PrepQuant System, an integrated sample preparation platform designed to standardize and streamline pre-analytical workflows. The system automates and organizes sample processing steps to ensure consistent quality and accuracy across tests, supporting molecular diagnostics and improving laboratory efficiency. It is designed to enhance workflow reliability, reduce variability in sample preparation, and enable laboratories to handle higher testing volumes in high-demand diagnostic environments.

In March 2023, Brooks Automation US LLC, a US-based science and technology company, acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. Through this acquisition, Brooks aims to expand its capabilities in clinical laboratory automation by integrating Aim Lab’s robotic instrumentation and pre-analytical automation technologies, thereby strengthening its presence beyond drug discovery into the diagnostics market. Aim Lab Automation Technologies Pty Ltd. is an Australia-based company specializing in the design and manufacturing of robotic systems, including autosamplers, tube decappers, and modular solutions for pre- and post-analytical laboratory processes.

Major companies operating in the pre-analytical automation market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Roche Diagnostics International AG, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Sysmex Corporation, PerkinElmer's Life Sciences & Diagnostics business, Tecan Group Ltd., Sarstedt Aktiengesellschaft And Co. KG, Hamilton Company, Brooks Automation Inc., Inpeco SA, Automata Technologies Limited, Opentrons Labworks Inc., BICO Group AB, Peak Analysis and Automation Limited, Hudson Robotics Inc., Dynamic Devices Ltd., Aurora Biomed Inc., VEON Scientific Limited.

North America was the dominant region in the pre-analytical automation market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in pre-analytical automation report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pre-analytical automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pre-analytical automation market consists of revenues earned by entities by providing services such as sample collection management, specimen sorting, labeling, centrifugation, aliquoting, and sample tracking prior to laboratory analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The pre-analytical automation market also includes sales of automated sample preparation systems, robotic handling equipment, and conveyor systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pre-analytical automation market research report is one of a series of new reports that provides pre-analytical automation market statistics, including pre-analytical automation industry global market size, regional shares, competitors with a pre-analytical automation market share, detailed pre-analytical automation market segments, market trends and opportunities, and any further data you may need to thrive in the pre-analytical automation industry. This pre-analytical automation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.